Genertec Universal Medical Group Co. Ltd. reported a stable and improving operation for the first quarter of 2025. During this period, the Group's sales increased by approximately 16.1% compared to the same period in 2024. The profit for the period also saw an increase of about 14.3% compared to the previous year, with the profit attributable to owners of the parent rising by approximately 16.7%. In the integrated healthcare business segment, the Group made significant efforts to enhance the quality and efficiency of healthcare services. This was achieved through standardized disease management, optimizing medical resource utilization, and ensuring effective treatment and service quality. The member medical institutions under the Group noted an increase in outpatient and emergency visits, demonstrating strong performance in the first quarter of 2025.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.